Understanding how SGLT2 inhibitors protect from heart failure
Description preview
SUMMARY
Heart failure is a leading cause of death worldwide, and the leading cause of hospital admissions in patients
over 65 in the US. The role of metabolism in cardiac pathology has long been of interest, but no therapies that
target cardiac metabolism are known. Recently, Na+/glucose transporter 2 inhibitors (SGLT2i), originally
designed as…
Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click